Patents Assigned to Foghorn Therapeutics Inc.
  • Compounds and uses thereof
    Patent number: 11851445
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: December 26, 2023
    Assignee: FOGHORN THERAPEUTICS INC.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt
  • BRD9 degraders and uses thereof
    Patent number: 11787800
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: October 17, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton, Francois Brucelle
  • Methods and compounds for treating disorders
    Patent number: 11773085
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: October 3, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Qianhe Zhou, Michael Bocker, David Simon Millan, Ho Man Chan, Luis Soares, Matthew Russell Netherton, Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Francois Brucelle
  • Citrate salt, pharmaceutical compositions, and methods of making and using the same
    Patent number: 11767330
    Abstract: The present disclosure features citrate salts and pharmaceutical compositions useful for the treatment of BAF complex-related disorders. Also disclosed are methods for preparing compounds.
    Type: Grant
    Filed: July 6, 2022
    Date of Patent: September 26, 2023
    Assignee: FOGHORN THERAPEUTICS INC.
    Inventors: Chong-Hui Gu, Joshua D. Waetzig
  • COMPOUNDS AND USES THEREOF
    Publication number: 20230077730
    Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 16, 2023
    Applicants: Foghorn Therapeutics Inc., Foghorn Therapeutics Inc.
    Inventors: Sabine K. RUPPEL, Zhaoxia YANG, Jason T. LOWE, Johannes H. VOIGT, Matthew NETHERTON, Francois BRUCELLE
  • Compounds and uses thereof
    Patent number: 11560381
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: January 24, 2023
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton
  • Compounds and uses thereof
    Patent number: 11497752
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: November 15, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Neville John Anthony, David Simon Millan, Rishi G. Vaswani, Shawn E. R. Schiller
  • Compounds and uses thereof
    Patent number: 11485732
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: November 1, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Rishi G. Vaswani, David S. Huang
  • Compounds and uses thereof
    Patent number: 11414416
    Abstract: The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: August 16, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Sabine K. Ruppel, Zhaoxia Yang, Jason T. Lowe, Johannes H. Voigt, Matthew Netherton